Individuals with a known allergy to Tadalafil or Paroxetine or any inactive ingredients in the formulation.
Patients taking nitrates (e.g., nitroglycerin) or medications that enhance nitric oxide (risk of severe hypotension).
Individuals taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy, as this significantly increases the risk of serotonin syndrome.
Those using other serotonergic drugs, such as other SSRIs, SNRIs, triptans, tramadol, or St. John’s Wort, without proper medical supervision.
Individuals with a known allergy to Tadalafil or Paroxetine or any inactive ingredients in the formulation.
Patients with severe cardiovascular, liver, or kidney conditions, or a history of priapism or retinal disorders.
Pregnant or breastfeeding individuals unless deemed necessary by a healthcare provider.
Comments
0 comments
Article is closed for comments.